• OPEN AN ACCOUNT
Indian Indices
Sensex
73,123.83 -125.56
( -0.17%)
Global Indices
Nasdaq
52,891.50 14.41
(0.03%)
Dow Jones
7,684.38 -93.79
(-1.21%)
Hang Seng
62,584.98 -322.86
(-0.51%)
Nikkei 225
10,723.99 -28.89
(-0.27%)
Forex
USD-INR
94.51 -0.31
(-0.33%)
EUR-INR
106.10 -0.35
(-0.33%)
GBP-INR
126.51 -0.13
(-0.10%)
JPY-INR
0.60 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Hindalco Industries Ltd
Industry :  Aluminium and Aluminium Products
BSE Code
ISIN Demat
Book Value()
500440
INE038A01020
341.4952697
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
HINDALCO
15.35
199553.71
EPS(TTM)
Face Value()
Div & Yield %
57.85
1
0.56
 

jaiprakash power ventures ltd
Lupin appoints Brian Savage as President, Chief Legal Officer
Oct 23,2026
Lupin announced the appointment of Brian Savage as President, Chief Legal Officer. Brian will lead Lupin's global Legal, Compliance, and Intellectual Property Management Group (IPMG) functions, and will be based in New Jersey.

Brian joins Lupin from Teva Pharmaceuticals, where he held several senior leadership roles since 2015. Most recently, he served as Teva's Executive Vice President and Interim Global Chief Legal Officer. During his tenure, he also led Teva's global litigation strategy and served as General Counsel for its U.S. Generics business.

Prior to joining Teva, Brian practiced law at Dechert LLP. Brian brings extensive experience navigating the complex legal and regulatory landscape in the global pharmaceutical industry. He holds a Juris Doctor (J.D.) from Yale Law School and a B.A., summa cum laude, from the University of Pennsylvania.